Tang Capital takes stake in Cyclacel Pharmaceuticals By: MarketMinute.com Stock News August 22, 2016 at 19:07 PM EDT Tang Capital Partners acquired a 9.6% stake in Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC). The stock price climbed $1.35 to close at $8.28. Related Stocks: Cyclacel Pharmaceuti